Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Keratoacanthoma differential

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Recognise the rapidly growing crateriform keratoacanthoma pattern, understand why it cannot be safely distinguished from well-differentiated SCC clinically, and arrange urgent complete histological assessment.

  • A classic keratoacanthoma is a rapidly growing, symmetrical, dome-shaped nodule with a central keratin-filled crater on sun-exposed skin.
  • Growth over two to eight weeks is typical, but speed does not prove benignity; SCC can show the same crateriform pattern.
  • Manage a solitary suspected keratoacanthoma as SCC until complete architecture and depth have been assessed histologically.
  • Urgent complete excision is preferred when feasible because partial punch or superficial shave may not show the diagnostic shoulders and deep interface.
  • Do not observe for spontaneous regression when SCC cannot be excluded, especially in immune suppression or high-risk sites.
  • Palpate regional nodes and ask about pain, numbness and weakness in a rapidly growing keratinising tumour.
  • Multiple synchronous lesions should trigger medicine, immune and family-history review and specialist dermatology care.
  • Destructive treatment such as curettage or cryotherapy without adequate histology risks erasing an SCC diagnosis.

Key red flags

Rapid growth, pain, lip or ear site, size over 2 cm, immune suppression, recurrence, fixation, neurological symptoms or a regional node increases SCC risk and requires urgent specialist assessment.

Rapid growth

Increase from papule to centimetre-scale tumour within several weeks is characteristic and itself triggers urgent assessment.

High-risk departure

Irregular infiltration, fixation, neurological symptoms, lip or ear location, recurrence or palpable nodes heightens SCC concern.

Investigation priorities

01
Complete excision histologyFirst step

Assess full crater architecture, invasive front, differentiation and margins while treating the lesion.

Management branches

Solitary crateriform lesionTreat as SCC until proven otherwise

A rapidly growing keratin-filled nodule is clinically compatible with keratoacanthoma.

  1. Document growth, site, size, neurological symptoms, immune state and nodes and make an urgent suspected-cancer referral.
  2. Arrange complete excision with adequate depth when feasible, preserving the specimen and orientation for histopathology.
  3. Review the definitive report and manage margins and surveillance according to the SCC risk assessment.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Association of Dermatologists keratoacanthomaClinical pattern, SCC overlap and treatment.
  • BAD cutaneous SCC guideline 2020Crateriform SCC diagnosis and management context.
  • NICE NG12 suspected cutaneous SCC referralUrgent referral of suspected SCC.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom